0000000001091837

AUTHOR

Artur Pałasz

showing 3 related works from this author

Amantadine in the Treatment of Sexual Inactivity in Schizophrenia Patients Taking Atypical Antipsychotics—The Pilot Case Series Study

2021

Sexual dysfunctions in people with schizophrenia are more severe than in the general population and are an important element in the treatment of schizophrenia. The mechanism of sexual dysfunction in patients treated for schizophrenia may be related to the side effects of antipsychotic drugs (hyperprolactinemia, suppression of the reward system), but it may also be related to the pathogenesis of schizophrenia itself. The aim of the study was to present the possibility of using amantadine in the treatment of sexual dysfunction in schizophrenia without the concomitant hyperprolactinemia. In an open and naturalistic case series study, five men treated for schizophrenia in a stable mental state …

libidomedicine.medical_specialtymedicine.medical_treatmentPopulationantipsychotic drugsPharmaceutical SciencePharmacy and materia medicahyperprolactinemiaDrug Discoverymental disordersMedicineeducationAntipsychoticPsychiatryLibidoeducation.field_of_studyamantadinesex drivebusiness.industryCommunicationatypical antipsychoticsAmantadineRmedicine.diseasesexual disfunctionsRS1-441schizophreniaSexual desireSexual dysfunctionSchizophreniaMolecular MedicineMedicinemedicine.symptombusinessCase seriesmedicine.drugPharmaceuticals
researchProduct

Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity

2020

Membrane phospholipase D (PLD) is associated with numerous neuronal functions, such as axonal growth, synaptogenesis, formation of secretory vesicles, neurodegeneration, and apoptosis. PLD acts mainly on phosphatidylcholine, from which phosphatidic acid (PA) and choline are formed. In turn, PA is a key element of the PLD-dependent secondary messenger system. Changes in PLD activity are associated with the mechanism of action of olanzapine, an atypical antipsychotic. The aim of the present study was to assess the effect of short-term administration of the first-generation antipsychotic drugs haloperidol, chlorpromazine, and fluphenazine on membrane PLD activity in the rat brain. Animals were…

0301 basic medicineFluphenazineolanzapinePhospholipasePharmacologyCatalysishaloperidollcsh:ChemistryInorganic Chemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineneurotoxicityHaloperidolmedicineAnimalsphospholipase DPhospholipase D activityPhysical and Theoretical ChemistryChlorpromazinechlorpromazinelcsh:QH301-705.5Molecular BiologySpectroscopy030102 biochemistry & molecular biologyPhospholipase DCommunicationOrganic ChemistryGeneral MedicinePhosphatidic acidfluphenazineRatsComputer Science ApplicationsEnzyme Activationenzymes and coenzymes (carbohydrates)lcsh:Biology (General)lcsh:QD1-999chemistryMechanism of actionneuroprotectionlipids (amino acids peptides and proteins)medicine.symptom030217 neurology & neurosurgerymedicine.drugInternational Journal of Molecular Sciences
researchProduct

The Effect of Smartphone-Based Cognitive Training on the Functional/Cognitive Markers of Schizophrenia: A One-Year Randomized Study

2020

Background: Cognitive impairment is associated with long-term disability that results in the deterioration of both the social and professional status of individuals with schizophrenia. The impact of antipsychotic therapy on cognitive function is insufficient. Cognitive training is therefore proposed as a tool for cognitive rehabilitation in schizophrenia. In this study we investigated the effect of self-administered cognitive training using a smartphone-based application on the cognitive function of paranoid schizophrenia patients focusing on response time, correct answer rate, incorrect answer rate, and fatigability to check, if these functions can be functional markers of successful cogni…

paranoid schizophrenia; cognitive impairment; cognitive training; cognitive markers; functional markers; smartphone application; telephone-based intervention; cognitive remediation therapyParanoid schizophreniamedicine.medical_specialtymedicine.medical_treatmentlcsh:Medicinecognitive markersArticlefunctional markerscognitive training03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationMedicineCognitive skillCognitive rehabilitation therapysmartphone applicationparanoid schizophreniacognitive remediation therapycognitive impairmentRehabilitationbusiness.industrytelephone-based interventionlcsh:RCognitionGeneral Medicinemedicine.diseaseCognitive training030227 psychiatrySchizophreniaCognitive remediation therapybusiness030217 neurology & neurosurgeryJournal of Clinical Medicine
researchProduct